Klonopin Articles

Roche in deal with moksha8 for Mexico

22 May 2009

Jazz' seizure drug gets FDA orphan status

14 January 2008

Par to begin shipping clonazepam ODT

15 August 2005

Second FDA drug imports "blitz" finds 80% come from Canada

9 February 2004

Generics "can be dearer in Canada than USA"

26 January 2004

Caraco expects $35M revenues in 2003

24 February 2003

Caraco gets US OK for metformin/tramadol

4 February 2002

Teva earnings receive boost from Copaxone

13 May 1999

Teva's fortunes take turn for the better

25 February 1999

Pharmachemie Pushes Teva's Sales Up In Third Quarter

10 November 1998

FH Faulding Reviews "A Year Of Major Change"

3 November 1998

"Worst And Most Difficult Quarter" For Years at Teva

10 August 1998

Teva Focus On New Generics

8 July 1998

Teva Issues Another Profits Warning

17 June 1998

Teva Looking To Euro Buy As Profits Fall

13 May 1998

Roche Sales Grew 18% In 1997; Pharma Up 15%

16 January 1998

Epilepsy Market Sees Strong Growth

29 July 1997

Teva's Strength: Coping With Change

21 July 1997

Solid First Half At Roche As Posicor Is Approved

16 July 1997

First-Quarter Sales At Roche Up 18%

21 April 1997

1996 A Year Of M&As For Teva Pharmaceuticals

3 March 1997

Teva And Developments In The US Generics Market

25 November 1996

Interim Financial Results From The USA

18 November 1996

Teva's Copaxone "Approvable" In USA

14 October 1996

US Appro For Teva's Clonazepam

23 September 1996

ABPI Highlights Advances In Epilepsy Treatment

6 May 1996

Higher-Priced Drugs Set To Expand Epilepsy Market

12 February 1996

LIKELY IMPACT ON DRUG FIRMS OF ITALIAN REFORMS

17 January 1994

WORLD CNS MARKET IS LARGE AND FRAGMENTED

22 February 1993

Showing 1-29 of 29 articles

Go to beginningPrevious
  • 1
NextGo to end